The level of CXCR4 expressing fibrocytes is enhanced in the blood of COPD patients during an exacerbation, and the chemotactic properties of these cells in response to CXCL12 are also increased [76]. The gene discussed is CXCR4; the disease is chronic obstructive pulmonary disease.